[{"Assets_0_Q2_USD":"257445000.0","CIK":"1595893","CommonStockSharesConverted_0_Q2_shares":"31297423.0","CommonStockSharesOutstanding_0_Q2_shares":"31297423.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.7","EarningsPerShareBasic_2_Q2_USD":"-2.19","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1579986704.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-27139000.0","NetIncomeLoss_1_Q2_USD":"-17142000.0","NetIncomeLoss_2_Q2_USD":"-30689000.0","OfficialName":"Turning Point Therapeutics Inc. Common Stock","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"247915000.0","Ticker":"TPTX","filed":"20190806","footnote":null,"form":"10-Q","fp":"Q2","fy":"2019.0","name":"TURNING POINT THERAPEUTICS, INC.","period":"20190630","qtrs":"0","uom":"USD"}]